Chat with us, powered by LiveChat

 Speaker Profile

M.D., Professor, Yale

Biography
Kevan Herold, MD is Professor of Immunobiology and Internal Medicine at the Yale School of Medicine. His career has involved translational studies of the pathogenesis and treatment of immune diseases. He has been the PI of the clinical trials that led to the approval of teplizumab for treatment and prevention of Type 1 diabetes in addition to other immunologic and metabolic agents. His work has spanned a number of aspects of the pathogenesis of autoimmune diabetes including the immune mechanisms and the effects of autoimmunity on beta cells, with studies in preclinical and with clinical samples. His lab identified a subpopulation of beta cells that appear to resist immune attack. He developed an assay to measure β cell death in vivo and described changes in beta cells that occur in response to immunologic stressors which, he postulated may enable their survival


 Session Abstract – PMWC 2027 Silicon Valley

Showcase Track S2 - Jan 27 9.15 A.M.-5.00 P.M.,Showcase Track S2 - Jan 28 9.15 A.M.-12.00 P.M.,Showcase Track S2 - Jan 29 1.15 P.M.-1.30 P.M.


Track Chair:
Mark Genovese, Eli Lilly

PMWC Award Ceremony
• Miriam Merad, Mount Sinai (Luminary)
• Jeffrey A. Bluestone, UCSF (Luminary)

Featured Speakers
• Miriam Merad, Mount Sinai
• Jeffrey A. Bluestone, UCSF
• Gallia Levy, Gilead
• Marcela V. Maus, Harvard
• Nick Wilson, Biogen
• Megan Levings, BC Children's Hospital Research Institute
• Min Bao, Kali Therapeutics
• Purvesh Khatri, Stanford
• Heleen Scheerens, Genentech
• Pascal Geldsetzer, Stanford
• Dan Littman, NYU
• Anne Kasmar, Parexel

Macrophages Across Inflammation, Cancer & Aging
Master regulators of tissue health and disease across precision immunology.

Immune Reset in Autoimmune Disease
CAR-T, in vivo CAR, and the pursuit of durable remission.

Beyond Broad Immunosuppression
Tolerance, Tregs, and disease-modifying approaches.

Turning Biomarkers on Their Head
What we can measure before we can reliably predict response.

Precision Immunology in Clinical Development
Trial enrichment, deeper endpoints, response prediction, and regulatory strategy.

The Microbial Roots of Autoimmunity
Chronic infection, dysbiosis, and microbial signals shaping disease.

PMWC 2027 Silicon Valley - Program

PMWC Hall of Impact

Previous Speakers Include

Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.

×

Add Names/PO on Receipt

Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Save $1311 By AUG. 13
PMWC 2027 Jan. 27-29 • Santa Clara
15 tracks • 400 speakers Co-hosted by Stanford/UCSF/Yale • Davos of PM
SAVE $1311 Rate increases AUG. 13 LOCK IN RATE

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required

Apply to Speak at PMWC Silicon Valley by AUG. 13TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.